Clinical trials recruiting for Pancreatic Adenosquamous Carcinoma
4
Recruiting trials
44
US states with sites
8
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Phase 3 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nab-paclitaxel | 2 |
| 5-Fluorouracil | 1 |
| Autologous DC Therapy | 1 |
| Gemcitabine | 1 |
| Gemcitabine (GEM) | 1 |
| Irinotecan | 1 |
| Leucovorin (Calcium Folinate) | 1 |
| Olaparib | 1 |
| Oxaliplatin | 1 |
| Zoldonrasib | 1 |
| daraxonrasib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 3 |
| Florida | 3 |
| Texas | 3 |
| California | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Maryland | 2 |
| Nevada | 2 |
| New Jersey | 2 |
| New York | 2 |
| Ohio | 2 |
| Tennessee | 2 |
Top cities
Atlanta, Georgia 2Baltimore, Maryland 2Chicago, Illinois 2Cincinnati, Ohio 2Dallas, Texas 2Henderson, Nevada 2Houston, Texas 2New York, New York 2Salt Lake City, Utah 2San Francisco, California 2
Self-screener
Recruiting trials
- APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
Related conditions
Trials recruiting for Pancreatic Adenosquamous Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Pancreatic Adenocarcinoma 49PDAC - Pancreatic Ductal Adenocarcinoma 21PDAC 11Pancreatic Ductal Adenocarcinoma (PDAC) 32Pancreatic Cancer Metastatic 16Pancreatic Adenocarcinoma Metastatic 6Resectable Pancreatic Adenocarcinoma 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Adenosquamous Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.